CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to catalog somatic mutations and epigenomic changes in 500 breast cancer samples, specifically the estrogen receptor-positive and HER2-negative subtype. By using high coverage genome sequencing, the project seeks to enhance understanding of breast cancer biology and improve methods for early detection…
All cancers arise due to somatically acquired mutations in their genomes which alter the function of key cancer genes.
Understanding these critical mutational events underlying cancer development is paramount for advancing prevention, early detection, monitoring and treatment of the disease.
Breast cancer is the most common class of cancer diagnosed in women worldwide with more than one million cases diagnosed annually.
It is responsible for >400,000 deaths per year making it the leading cause o…
GENOME RESEARCH LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Norway, Oslo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Amsterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
STICHTING RADBOUD UNIVERSITEIT
Netherlands, Nijmegen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
